AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 74 min read$HCAT

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst (NASDAQ: HCAT) shares fell 23.1% after the company issued a weak Q3 revenue forecast and cut its full-year outlook. It expects Q3 revenue of $55.5 million versus $70.49 million in Q2, and reduced 2026 revenue guidance to $247.5 million at the midpoint. Q2 revenue met expectations, but the outlook pressured the stock.

Original reporting
financialcontent.com
Published Aug 7, 2026, 5:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Why Health Catalyst (HCAT) Shares Are Trading Lower Today — source image
Source · financialcontent.com
Decision brief

The 30-second read

$HCATBearishHigh
01

Why it matters

The guidance cut is the dominant catalyst, overwhelming the prior quarter’s beat and shifting expectations toward slower growth.

02

Market read

This is a guidance-driven repricing event with concrete quarterly and full-year revenue numbers, making it actionable for positioning and risk management.

03

What to watch

The article notes Q2 revenue beat and EPS meeting estimates, so traders may want to separate execution in Q2 from the forward revenue trajectory implied by the new forecast.

Relevance 9/10Novelty 9/10Timing: afternoon session selloff after Q3 and full-year guidance cut

Background

Health Catalyst topped Q2 revenue expectations but then issued a weak Q3 revenue forecast and reduced full-year 2026 revenue guidance.

Company-level read

Ticker impact

$HCATBearishHigh confidence
Context

Health Catalyst shares fell 23.1% after it guided Q3 revenue to $55.5M and cut full-year 2026 revenue to $247.5M (midpoint).

Expected impact

Near-term downside bias likely persists until investors see evidence of stabilization in bookings or re-acceleration in revenue.

Evidence & confidence

The article cites a weak sequential Q3 revenue forecast and a reduced full-year revenue midpoint, which are direct, decision-relevant inputs for valuation and expectations.

Market effects

Sector

Healthcare data analytics and analytics-software names may face read-across selling if investors generalize the demand slowdown.

Regional

Primarily US small/mid-cap growth sentiment impact via guidance-led repricing.

Global

Limited direct global spillover; mostly affects healthcare analytics investor expectations.

Counterpoint

What could challenge this read

The stock’s magnitude of decline could create a valuation dislocation if the revenue miss is temporary and driven by timing rather than structural demand.

Key entities

  • company
    Health Catalyst

    Healthcare data analytics company whose Q3 revenue forecast and full-year 2026 guidance were lowered, triggering a sharp selloff.

Read at source← All news

Related articles

AUG 6
$HCATMedAI 8/10

M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix

Health Catalyst, Inc. said it closed the July 31, 2026 sale of Vitalware, LLC to Med-Metrix, LLC. The divestiture generated $147M in total cash consideration, subject to adjustments. Health Catalyst plans to use proceeds and cash on hand to fully repay its credit facility, removing about $19M in annual GAAP interest expense, and to focus on its core healthcare intelligence and AI platform.

hitconsultant.net4 min
AUG 6
$HCATHigh

Health Catalyst, Inc. (HCAT): Results of Operations and Financial Condition

Health Catalyst, Inc. (HCAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2ex991-earningspress.htm EX-99.1 Document Exhibit 99.1 Health Catalyst Reports Second Quarter 2026 Results SALT LAKE CITY, UT, August 6, 2026 — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measur

SEC EDGAR 8-K6 min
AUG 7
$SGHighAI 9/10

Why Sweetgreen Stock Tumbled Today

Sweetgreen (SG) shares fell after the company missed Q2 estimates and cut full-year guidance, citing a cyclospora outbreak impact on demand even though it said it was not directly affected. Same-store sales fell 6.2% and revenue rose 3.8% to $192.7M. Restaurant margin and adjusted EBITDA deteriorated, and GAAP loss per share widened to $0.22.

fool.com4 min
AUG 7
$ASLEMedAI 8/10

AerSale (ASLE) Stock Trades Down, Here Is Why

AerSale (ASLE) shares fell 7.9% after the company reported Q2 results that missed earnings and revenue estimates. AerSale posted an adjusted loss of $0.09 per share versus a $0.07 profit expected, and revenue of $70.93 million, down 33.9% year over year. The stock is also down 19.1% YTD.

financialcontent.com3 min
AUG 7
$FROGHighAI 9/10

Why JFrog Stock Jumped Today

JFrog shares rose sharply after the company reported Q2 results. Revenue was $163.8 million, up 29% year over year, and adjusted EPS was $0.27, up 50%, versus analyst estimates of $155.64 million revenue and $0.24 EPS. Cloud revenue grew 53% to $87.5 million. JFrog raised its full-year revenue forecast to $650 million (midpoint).

fool.com4 min